Crunching the numbers for JNJ... Refresh in a moment for the full analysis.
JOHNSON & JOHNSON (JNJ)
Healthcare
Deep Overvalued
mixed
$243.0
Updated: 2026-04-12
57
TradeApes Score
hold
Financial Strength
60
Healthy
Operating Trend
58
Mixed
Valuation
50
Mixed
Capital Allocation
45
Mixed
Risk
80
Strong
Fair Value
$0.0
Sector Rank
#17
of 18
Key Findings
+
Free cash flow positive — business generates real spendable cash
−
Debt increasing — total debt up more than 10% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.